We stand for freedom. We stand with Ukraine.


The Supreme Court Is About To Affect Every Prescriber in America

May 5, 2022

In this Journal of Opioid Management op-ed, Center for U.S. Policy Senior Fellow Lynn Webster, M.D., and co-authors explain that state licensing boards and civil lawsuits, along with the federal government’s administrative framework, are more appropriate forums than federal criminal courts when dealing with questions surrounding medical care

New Resources Educate Decision Makers on Insurance Coverage of Rx Digital Therapies

March 28, 2022

Thirty-three not-for-profit organizations sent a letter to commend Members of Congress for introducing a bill to provide Medicare coverage and create a new Medicaid payment category for prescription digital therapies. The “Access to Prescription Digital Therapeutics Act of 2022” is sponsored by Sens. Jeanne Shaheen (NH) and Shelley Moore Capito (WV), and Reps. Mike Thompson (CA-5) and David McKinley (WV-01).

Federal Government Facilitates Access To Rx Digital Behavioral Therapies

March 23, 2022

The Center for U.S. Policy, Aimed Alliance, and the International Health Facility Diversion Association commended the federal government for facilitating patient access to prescription digital behavioral therapies. “We thank CMS for acting with speed to expand access to evidence-based digital therapies for behavioral health.”

“Not all health care professionals subject to the DOJ’s searches and seizures are ‘dirty docs.’ In fact, some of them are nationally recognized leaders not just in pain management, but also in addiction medicine”

A More Sensible Surge: Ending DOJ's Indiscriminate Raids of Healthcare Providers
Legislation & Policy Brief

Collaborating Organizations


Center for U.S. Policy


Newsletter Sign-up

We commend @HHSGov’s awards to states, tribes of $1.5 billion to address #substanceusedisorder. Funding will promote #recovery by #IncreasingAccess to 24/7 treatment programs and removing barriers to medications for #opioidusedisorder. #RecoveryMonth https://www.whitehouse.gov/briefing-room/statements-releases/2022/09/24/what-they-are-reading-in-the-states-biden-harris-administration-awards-1-5-billion-to-states-and-tribes-to-combat-overdose-epidemic/

.@US_FDA exempts #harmreduction programs distributing #opioid-reversal drug #naloxone from federal product tracking requirements to increase availability and access. Read FDA’s newly released guidance here:

We support inclusivity and transparency in the administration and disbursement of #opioidlitigation proceeds. https://woub.org/2022/08/10/drug-policy-reform-group-sues-the-board-responsible-for-spending-half-of-ohios-opioid-settlement-money/

We are pleased to announce that our Chairman @MCBtweets will be special editor of the legal-legislative-regulatory issue of the Journal of Opioid Management.

Learn more here: https://www.wmpllc.org/ojs/index.php/jom/pages/view/Legal

Load More...